Home/Eikon Therapeutics/Dr. Roger D. Perlmutter
DR

Dr. Roger D. Perlmutter

Chairman and Chief Executive Officer

Eikon Therapeutics

Therapeutic Areas

Eikon Therapeutics Pipeline

DrugIndicationPhase
EIK-001Oncology (Undisclosed)Preclinical
EIK-002Immunology/Inflammation (Undisclosed)Preclinical
EIK-003Oncology (Undisclosed)Discovery
EIK-004UndisclosedDiscovery
EIK-005UndisclosedDiscovery